Crossmark

Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s40425-019-0660-7

Published Online: 2019-07-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cai, Liangliang

Bai, Hua

Duan, Jianchun

Wang, Zhijie

Gao, Shugeng

Wang, Di

Wang, Shuhang

Jiang, Jun

Han, Jiefei

Tian, Yanhua

Zhang, Xue

Ye, Hao

Li, Minghui

Huang, Bingding

He, Jie

Wang, Jie https://orcid.org/0000-0002-5602-0487
Funding

Funding for this research was provided by:

National Natural Sciences Foundation Key Program (81630071)

Aiyou Foundation (KY201701)

Ministry of Education Innovation Team development project (IRT-17R10)
License Information

Text and Data Mining valid from 2019-07-26
More Information

Article History

Received: 12 February 2019

Accepted: 28 June 2019

First Online: 26 July 2019

Ethics approval and consent to participate

: Patients undergoing removal a primary tumor were consented in accordance with IRB-approved institutional protocols.

: Not Applicable.

: The authors declare that they have no competing interests.